Project Grant R01AI179758
- Federal Grant Award Summary L2 Diagnostics LLC received a $281,786 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on September 23, 2025, with a completion date of August 31, 2027. The company is developing a viral vector-based vaccine against Powassan virus (POWV), a tick-borne flavivirus, utilizing a Modified Vaccinia Ankara (MVA) vaccine platform. The vaccine design...
- The Research Foundation for the State University of New York at Stony Brook University will conduct research from August 1, 2022 to July 31, 2025 to inhibit Powassan virus persistence and spread to neuronal compartments under a $1.9 million Project Grant from the Department of the Army Medical Command. The research is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve military and public health outcomes. Specifically,...
- Federal Project Grant Award Summary Harvard Medical School received a $2.49 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on March 1, 2025, with a completion date of February 28, 2030. The grant supports research focused on characterizing innate immune signaling pathways in the tick Ixodes scapularis, a primary vector for Lyme disease and other tick-borne pathogens....
- The University of Maine System has been awarded a $2,021,000 Cooperative Agreement from the Environmental Protection Agency Office of Research and Development under the Congressionally Mandated Projects program (CFDA 66.202). The goal of this 4-year project is to examine how climate change impacts the seasonality and life cycle of ticks, a key vector for disease transmission. Key activities include: 1) researching the molecular and hormonal factors regulating tick diapause in relation to climate...
- Federal Project Grant Award Summary The National Science Foundation (NSF) Division of Environmental Biology awarded Columbia University $2,459,664 under the Biological Sciences program (CFDA 47.074) for a five-year project (September 1, 2025–August 31, 2030) to investigate eco-social dynamics of tick-borne pathogens along urbanization gradients in metropolitan areas including New York and Boston. The project will deliver integrated research outputs combining wildlife sampling, tick surveillance,...
- Federal Grant Award Summary Boston University Medical Campus received a $449,625 Project Grant award dated July 8, 2025, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The two-year project, concluding July 7, 2027, focuses on developing novel research infrastructure and scientific understanding of arthropod-borne virus (ABV) transmission mechanisms. The primary deliverable is the development of an...
- This Cooperative Agreement award from the U.S. Geological Survey under its Research and Data Collection program (CFDA 15.808) will implement advanced molecular detection methods to monitor tick-borne pathogens and identify their host bloodmeal sources in the National Parks. Cornell University, the prime awardee, will use a hybrid capture sequencing approach to detect and characterize bacterial, protozoal, and viral pathogens in ticks, as well as analyze tick bloodmeals to gather information on...
- Federal Project Grant Award Summary The University of Connecticut Health Center received a $457,875 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025, through June 30, 2027. The award supports biomedical research investigating the role of the RpoS (sigma factor) regulatory protein in the persistence of Borrelia burgdorferi, the spirochete bacterium that causes...
- This Project Grant award of $392,500.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports a research program at Arizona State University (ASU) focused on improving the understanding of cross-species viral transmission from wild mammals to humans. The key objectives of the five-year project are to: 1) develop automated tools to curate and maintain up-to-date taxonomic data on mammal and virus species, 2) test...
- The National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) has awarded a $179,544 project grant to the Cary Institute of Ecosystem Studies, Inc. in Millbrook, NY. The funding will support research to evaluate the effects of spongy moth defoliation on blacklegged ticks, the primary vectors of Lyme disease and other tick-borne illnesses in the United States. The project aims to investigate how changes in ground-level temperature and humidity caused by spongy moth outbreaks may...
POWASSAN VIRUS EVOLUTION, FITNESS, AND PATHOGENESIS IN THE NORTHEAST AND MIDWEST UNITED STATES - PROJECT SUMMARY TICK-BORNE POWASSAN VIRUS (POWV) IS AN EMERGING PUBLIC HEALTH THREAT, BUT HAS BEEN UNDERSTUDIED TO DATE. SINCE ITS DISCOVERY IN 1958, HUMAN CASES OF POWV HAVE BEEN REPORTED IN THE UNITED STATES, CANADA, AND RUSSIA. STARTING IN 2006, CONFIRMED CASES OF POWV HAVE INCREASED IN BOTH FREQUENCY AND SCOPE IN NEW ENGLAND AND THE UPPER MIDWEST. NOTABLY, POWV IS NOW CONSIDERED AN EMERGING PUBLIC HEALTH THREAT BECAUSE IT HAS BEEN FREQUENTLY ASSOCIATED WITH THE AGGRESSIVE, HUMAN-BITING BLACKLEGGED TICK VECTOR, IXODES SCAPU- LARIS. THE FUTURE SPREAD OF POWV IS UNPREDICTABLE, BUT IT WILL BE IMPORTANT TO UNDERSTAND THE POTENTIAL FOR MORE WIDESPREAD EMERGENCE. THE GOALS OF THIS PROJECT ARE TO EVALUATE WHETHER THERE ARE REGIONAL, LOCAL, AND EVEN HYPERLOCAL DIFFERENCES IN THE GENETIC STRUCTURE OF TICK AND POWV POPULATIONS THAT AFFECT PATTERNS OF POWV HOST/VECTOR COMPETENCE, VIRULENCE, AND EVOLUTION. THESE QUESTIONS ARE IMPORTANT BECAUSE OUR KNOWLEDGE OF HOW TICK-BORNE FLAVIVIRUSES ARE MAINTAINED IN DISTINCT TRANSMISSION FOCI AND HOW NEW TRANSMISSION FOCI EMERGE IS LIMITED. ACCORDINGLY, THROUGH THIS NIH/NIAID R01, WE WILL SEEK TO EXAMINE THESE RELATIONSHIPS ACROSS MINNE- SOTA AND NEW YORK, TWO STATES WITH INCREASING BURDENS OF TICK-BORNE DISEASE RISK. THERE ARE 3 SPECIFIC AIMS: 1. ASSESS THE DISTRIBUTION AND GENETIC STRUCTURE OF POWV AND IXODES SCAPULARIS FROM DISTINCT FOCI IN THE NORTHEAST (NY) AND MIDWEST (MN) U.S. 2. EVALUATE THE EXTENT TO WHICH TICK POPULATION INTERACTS WITH VIRAL GENOTYPE TO DRIVE LOCAL ADAPTA- TION AND REGIONAL VARIABILITY IN IXODES SCAPULARIS COMPETENCE FOR POWV. 3. DETERMINE HOW POWV GENETIC VARIABILITY AND REGIONAL SELECTIVE PRESSURES IMPACT HOST COMPE- TENCE AND DISEASE HETEROGENEITY. IN THESE STUDIES, WE WILL EXPAND POWV SURVEILLANCE ACTIVITIES IN MN TO INTENSELY SAMPLE POWV GENOMES AND TICK POPULATIONS FROM ACROSS THE STATE. THE NY STATE DEPARTMENT OF HEALTH HAS A ROBUST POWV SURVEILLANCE PROGRAM IN PLACE FOR THIS PROJECT THAT WE WILL LEVERAGE. WE WILL ALSO SEEK TO UNDERSTAND THE PHENOTYPIC AND GE- NOTYPIC UNDERPINNINGS OF VIRUS-HOST DYNAMICS FOR POWV USING MOUSE AND TICK EXPERIMENTAL SYSTEMS. THESE STUDIES ARE CRITICALLY IMPORTANT BECAUSE POWV LIKELY WILL CONTINUE TO EMERGE IN THE FUTURE. THEREFORE, UNDER- STANDING HOW POWV OVERCOMES EVOLUTIONARY BARRIERS TO EMERGE AND CAUSE DISEASE IN HUMANS WILL BE CRITICAL FOR PREDICTION, PREVENTION, AND CONTROL OF THIS ARBOVIRAL DISEASE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $699.9k | 7/8/25 | ||
| Not listed | $749.4k | 6/28/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
SUBA00000164A011222001S | Minnesota Department Of Health | Project Grant R01AI179758 | $92.9k | 12/5/24 |